Intravitreal bevacizumab for retinal capillary haemangioma: longterm results
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.
PURPOSE To evaluate the therapeutic effect of intravitreal bevacizumab injection for symptomatic retinal arterial macroaneurysm. DESIGN Retrospective interventional case series. METHODS The study included 23 patients (23 eyes) with symptomatic retinal arterial macroaneurysm. They were categorized according to treatment method into 2 groups: an intravitreal bevacizumab-treated group (11 eyes...
متن کاملMassive Exudative Retinal Detachment Following Photodynamic Therapy and Intravitreal Bevacizumab Injection in Retinal Capillary Hemangioma
ment was recommended, but the patient initially refused. As the clinical findings did not change during follow-up, surgery was performed in August 2014. Restriction of the inferior rectus muscle of the left eye was confirmed through the forced duction test. During surgery, conjunctival scarring over the inferior rectus muscle was noted, in addition to a linear scar along the medial border of th...
متن کاملOutcomes of Intravitreal bevacizumab in patients with acute branch retinal vein occlusion
Introduction: The study aimed to evaluate the long-term effects of intravitreal bevacizumab on macular edema and visual acuity in patients with Acute branch Retinal Vein Occlusion (BRVO) that had not received any treatment. Methods: 22 patients in first week of BRVO onset that was diagnosed with flurcein angiography were treated with intravitreal injection of 1.25 mg bevacizumab. Macular thicke...
متن کاملRetinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
PURPOSE To evaluate the short-term efficacy and safety of intravitreal bevacizumab injection (IVBI) in patients with retinal angiomatous proliferation (RAP). METHODS Seven eyes of 5 patients with RAP were included in this study. All of the eyes evidenced stage 2 RAP lesions, except for one eye with a stage 3 lesion. IVBI (1.25 mg/0.05 cc) were conducted at 4 or 6-week intervals. Complete ocul...
متن کاملIntravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
PURPOSE To report a case of neovascular glaucoma due to central retinal artery occlusion treated with a single intravitreal injection of bevacizumab. METHODS A 68-year-old patient with a 10-week history of central retinal artery occlusion presented with neovascularization of the iris and the angle and intraocular pressure of 30 mm Hg. The patient received a single injection of 1.25 mg bevaciz...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica
سال: 2009
ISSN: 1755-375X,1755-3768
DOI: 10.1111/j.1755-3768.2009.01594.x